Hepamerz%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252528l-Ornithine%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520l-Aspartate%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520-%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520lola%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252529

## Hepamerz (L-Ornithine L-Aspartate) ### Overview Hepamerz is a combination of the amino acids L-ornithine and L-aspartate. It is believed to work by promoting the detoxification of ammonia in the liver and brain. ### Primary Indications * Treatment of latent and manifest hepatic encephalopathy (HE). ### Adult Dosing * **Oral:** The typical dose is 6-18 grams per day, divided into 3 doses. * For latent HE: 6-12 grams per day. * For manifest HE: 12-18 grams per day. * **Intravenous (IV):** Typically 5-10 grams per day, administered as a continuous infusion over 24 hours. The exact IV dosing and duration depend on the severity of hepatic encephalopathy and clinical response. ### Pediatric Dosing * Information regarding the safety and efficacy of Hepamerz in pediatric patients is limited. Dosing in children should be individualized and determined by a qualified healthcare provider based on clinical judgment and available evidence. ### Dose Adjustments * No specific dose adjustments are routinely recommended for renal or hepatic impairment, as the drug is primarily metabolized in the liver and excreted by the kidneys. However, caution should be exercised, and close monitoring is advised in patients with severe hepatic or renal dysfunction. ### Contraindications * Hypersensitivity to L-ornithine L-aspartate or any of its excipients. * Severe renal insufficiency (serum creatinine > 3 mg/dL). * Hyperornithinemia-Hereditary orotic aciduria (rare genetic disorders). ### Adverse Effects * **Common:** Nausea, vomiting, abdominal pain, diarrhea, and flatulence. * **Less Common:** Dizziness, headache, fatigue, and skin rash. ### Key Drug Interactions * There are no significant known drug interactions with Hepamerz. ### Monitoring * Monitor for signs and symptoms of hepatic encephalopathy, including changes in mental status, confusion, and asterixis. * Monitor renal function (serum creatinine) in patients with pre-existing renal impairment or those receiving prolonged therapy. ### Clinical Pearls * Hepamerz is most effective when administered orally or intravenously as part of a comprehensive management plan for hepatic encephalopathy, which may include dietary protein restriction and other supportive therapies. * Oral administration should ideally be taken with or after meals to minimize gastrointestinal upset. * The duration of treatment depends on the clinical response and the underlying cause of hepatic encephalopathy. *** *Disclaimer: This information is intended for healthcare professionals and does not replace the need to consult the official prescribing information and relevant literature. Always verify current prescribing information before making clinical decisions.*